D-0092-2019 Class II Terminated

Recalled by LUPIN SOMERSET — Somerset, NJ

FDA drug recall D-0092-2019 was initiated by LUPIN SOMERSET on Oct 5, 2018 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications:Out of specification result noticed for total impurities observed during stability analysis The recall status is terminated (terminated Nov 8, 2022). Affected quantity: 2712 60-ml bottles.

Recall details

Product Type
Drugs
Report Date
Oct 31, 2018
Initiation Date
Oct 5, 2018
Termination Date
Nov 8, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2712 60-ml bottles

Product description

Fluocinolone Acetonide Topical Solution, USP 0.01%, 60ml Bottle, Manufactured for: Lupin Pharmaceutical, Inc. Baltimore, MD 21202 Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. NDC 43386-069-60

Reason for recall

Failed Impurities/Degradation Specifications:Out of specification result noticed for total impurities observed during stability analysis

Distribution pattern

Nationwide in the USA

Code information

Lot# M16666, EXP 12/2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0092-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0092-2019. Report a data issue: hello@regdatalab.com.